BBH vs. PBPH
BBH (VanEck Vectors Biotech ETF) and PBPH (Portfolio Building Block World Pharma and Biotech Index ETF) are both Health & Biotech Equities funds - BBH tracks the MVIS US Listed Biotech 25 Index while PBPH tracks the BITA Global Pharma and Biotech Select Index. Both are passively managed. Their correlation of 0.84 suggests significant overlap in exposure. BBH charges 0.35%/yr vs 0.13%/yr for PBPH.
Performance
BBH vs. PBPH - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, BBH achieves a -1.85% return, which is significantly lower than PBPH's -1.13% return.
BBH
- 1D
- 2.22%
- 1M
- 0.09%
- YTD
- -1.85%
- 6M
- -5.32%
- 1Y
- 23.92%
- 3Y*
- 6.14%
- 5Y*
- 0.31%
- 10Y*
- 5.75%
PBPH
- 1D
- 0.58%
- 1M
- 0.07%
- YTD
- -1.13%
- 6M
- -0.02%
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
BBH vs. PBPH - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
BBH VanEck Vectors Biotech ETF | -1.85% | -3.14% |
PBPH Portfolio Building Block World Pharma and Biotech Index ETF | -1.13% | 0.76% |
Correlation
The correlation between BBH and PBPH is 0.84, indicating a strong positive relationship between their price movements. Combining them offers limited diversification - they tend to fall together during downturns.
| Correlation | |
|---|---|
Correlation (All Time) Calculated using the full available price history since Nov 26, 2025 | 0.84 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BBH vs. PBPH — Risk / Return Rank
BBH
PBPH
BBH vs. PBPH - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for VanEck Vectors Biotech ETF (BBH) and Portfolio Building Block World Pharma and Biotech Index ETF (PBPH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| BBH | PBPH | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | — | — | |
| Sortino ratioReturn per unit of downside risk | — | — | |
| Omega ratioGain probability vs. loss probability | 1.22 | — | — |
| Calmar ratioReturn relative to maximum drawdown | 2.28 | — | — |
| Martin ratioReturn relative to average drawdown | 5.81 | — | — |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| BBH | PBPH | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.26 | — | — |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.01 | — | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.26 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.38 | -0.04 | +0.43 |
Drawdowns
BBH vs. PBPH - Drawdown Comparison
The maximum BBH drawdown since its inception was -72.70%, which is greater than PBPH's maximum drawdown of -11.10%. Use the drawdown chart below to compare losses from any high point for BBH and PBPH.
Loading charts...
Drawdown Indicators
| BBH | PBPH | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -72.70% | -11.10% | -61.60% |
Max Drawdown (1Y)Largest decline over 1 year | -10.55% | — | — |
Max Drawdown (3Y)Largest decline over 3 years | -22.74% | — | — |
Max Drawdown (5Y)Largest decline over 5 years | -39.86% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -39.86% | — | — |
Current DrawdownCurrent decline from peak | -13.81% | -8.69% | -5.12% |
Average DrawdownAverage peak-to-trough decline | -20.75% | -4.23% | -16.52% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.13% | — | — |
Volatility
BBH vs. PBPH - Volatility Comparison
Loading charts...
Volatility by Period
| BBH | PBPH | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.06% | — | — |
Volatility (6M)Calculated over the trailing 6-month period | 14.28% | — | — |
Volatility (1Y)Calculated over the trailing 1-year period | 19.02% | 16.78% | +2.24% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 21.50% | 16.78% | +4.72% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 22.17% | 16.78% | +5.39% |
BBH vs. PBPH - Expense Ratio Comparison
BBH has a 0.35% expense ratio, which is higher than PBPH's 0.13% expense ratio.
Dividends
BBH vs. PBPH - Dividend Comparison
BBH's dividend yield for the trailing twelve months is around 0.51%, more than PBPH's 0.09% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BBH VanEck Vectors Biotech ETF | 0.51% | 0.51% | 0.80% | 0.43% | 0.47% | 0.21% | 0.36% | 0.34% | 0.50% | 0.55% | 0.30% | 0.27% |
PBPH Portfolio Building Block World Pharma and Biotech Index ETF | 0.09% | 0.09% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
BBH and PBPH have a correlation of 0.84, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, PBPH is cheaper at 0.13% per year. The better choice depends on whether you care most about return, fees, risk, or income.
PBPH is cheaper with a 0.13% expense ratio, compared with 0.35% for BBH.
BBH has the higher dividend yield at 0.51%, compared with 0.09% for PBPH.
BBH tracks MVIS US Listed Biotech 25 Index, while PBPH tracks BITA Global Pharma and Biotech Select Index. They also come from different issuers: VanEck and Portfolio Building Block. Their fees differ too: 0.35% for BBH and 0.13% for PBPH.
Find the right allocation for BBH and PBPH
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer